Why the study?
Arrhythmias during early reperfusion after MI are common and dangerous, but large animal evidence on reactive oxygen species and the effects of systemic antioxidative treatment remain scarce and contentious.
Does intravenous N-acetylcysteine reduce myocardial oxidative stress and prevent ischemia-reperfusion arrhythmias in a porcine model of myocardial infarction?
Does intravenous N-acetylcysteine reduce myocardial oxidative stress and prevent ischemia-reperfusion arrhythmias in a porcine model of myocardial infarction?
In a porcine model of myocardial infarction, systemic antioxidative treatment with N-acetylcysteine did not protect against early reperfusion arrhythmias despite evidence of increased myocardial oxidative stress.
Antioxidative therapy does not prevent reperfusion arrhythmias despite elevated myocardial oxidation in pigs; leaves open whether targeted interventions merit clinical testing.
Background: Arrhythmias in the early phase of reperfusion after myocardial infarction (MI) are common, and can lead to hemodynamic instability or even cardiac arrest. Reactive oxygen species (ROS) are thought to play a key role in the underlying mechanisms, but evidence from large animal models is scarce, and effects of systemic antioxidative treatment remain contentious. Methods: MI was induced in 7 male and 7 female pigs (Norwegian landrace, 35-40 kg) by clamping of the left anterior descending artery (LAD) during open thorax surgery. Ischemia was maintained for 90 min, before observation for 1 h after reperfusion. Pigs were randomized 1:1 in an operator-blinded fashion to receive either i.v. N-acetylcysteine (NAC) from 70 min of ischemia and onwards, or 0.9% NaCl as a control. Blood samples and tissue biopsies were collected at baseline, 60 min of ischemia, and 5 and 60 min of reperfusion. ECG and invasive blood pressure were monitored throughout. Results: The protocol was completed in 11 pigs. Oxidative stress, as indicated by immunoblotting for Malondialdehyde in myocardial biopsies, was increased at 5 min of reperfusion compared to baseline, but not at 60 min of reperfusion, and not reduced with NAC. We found no significant differences in circulating biomarkers of myocardial necrosis, nor in the incidence of idioventricular rhythm (IVR), non-sustained ventricular tachycardia (NSVT), ventricular tachycardia (VT) or ventricular fibrillation (VF) between NAC-treated and control pigs during reperfusion. Conclusion: Myocardial oxidation was increased early after reperfusion in a porcine model of MI, but systemic antioxidative treatment did not protect against reperfusion arrhythmias.
No takes yet. Share an insight, caveat, or question.
Hansen et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: